Allergan to acquire Bonti in strategic $195m deal to expand medical aesthetics pipeline

Irish pharmaceutical giant Allergan has announced its acquisition of Bonti, a U.S.-based aesthetic company specializing in fast-acting neurotoxin programs for aesthetic and therapeutic applications. The ... Read More